News

NeoGenomics (NEO) Targets Opportunity at $5 billion Liquid Biopsy Market
PanTracer LBx will strengthen NeoGenomics’ pan-solid tumor CGP portfolio and position it in the growing $3 to $5 billion ...
MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the Pharmacy Automation Quadrant Report 2025
Quadrants has released its latest Pharmacy Automation Startups/SMEs Companies Assessment, recognizing key players, including ...
Liquid Biopsy Market worth US$7.05 billion by 2030 with 11.8% CAGR | MarketsandMarkets™
The global Liquid Biopsy Market, valued at US$3.65 billion in 2024 stood at US$4.03 billion in 2025 and is projected to ...